Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril

Figures & data

Figure 1 Blood pressure control rates according to different cardiovascular risk conditions (after Barrios et al 2007c, d, e).

Abbreviations: CVD, cardiovascular disease; CHD, coronary heart disease; MetS, metabolic syndrome; CR, coronary risk; DM, diabetes mellitus.

Figure 2 Use of combined therapy according to different cardiovascular risk conditions (after Barrios et al 2007c, d, e).

Abbreviations: CVD, cardiovascular disease; CHD, coronary heart disease; MetS, metabolic syndrome; CR, coronary risk; DM, diabetes mellitus.

Figure 3 Blood pressure control rates achieved by the combination lercanidipine plus enalapril in different clinical trials (after Recordati 2004a, b; Agrawal et al 2006; Puig et al 2007). *p = NS; +p = 0.01.

Abbreviations: L, lercanidipine; E, enalapril; HTZ, hydrochlorothiazide.

BarriosVEscobarCCalderónA2007cBlood pressure and lipid goal attainment in the hypertensive population in the primary care setting in SpainJ Clin Hypertens (Greenwich)9324917485967

 PubMedGoogle Scholar

BarriosVEscobarCCalderónA2007dPrevalence of the metabolic syndrome in patients with hypertension treated in general practice in Spain: an assessment of blood pressure and low-density lipoprotein cholesterol control and accuracy of diagnosisJ Cardiometab Syndr291517684454

 PubMedGoogle Scholar

BarriosVEscobarCLlisterriJL2007eBlood pressure and lipid control and coronary risk in the hypertensive population attended in Primary Care setting in Spain. The PRESCOT studyRev Clin Esp207172817475179

 PubMed Web of Science ®Google Scholar

Recordati SpA2004aEfficacy and tolerability of a combination of lercanidipine and enalapril in patients with mild to moderate essential hypertension not adequately controlled by lercanidipine treatment (add-on to lercanidipine) [CPL1-0018]MilanRecordati SpA311[Data on file].

 Google Scholar

Recordati SpA2004bEfficacy and tolerability of a combination of lercanidipine and enalapril in patients with mild to moderate essential hypertension not adequately controlled by enalapril treatment (add-on to enalapril) [CPL1-0019]MilanRecordati SpA325[Data on file].

 Google Scholar

AgrawalRMarxAHallerH2006Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertensionJ Hypertens241859216331117

 PubMed Web of Science ®Google Scholar

PuigJGCalvoCLuurilaO2007Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: placebo-controlled, randomized, crossover study with four ABPMJ Hum Hypertens219172417581601

 PubMed Web of Science ®Google Scholar